CN110800914A - 一种用于二型糖尿病患者平稳血糖的食品配方 - Google Patents
一种用于二型糖尿病患者平稳血糖的食品配方 Download PDFInfo
- Publication number
- CN110800914A CN110800914A CN201810914758.4A CN201810914758A CN110800914A CN 110800914 A CN110800914 A CN 110800914A CN 201810914758 A CN201810914758 A CN 201810914758A CN 110800914 A CN110800914 A CN 110800914A
- Authority
- CN
- China
- Prior art keywords
- parts
- powder
- blood sugar
- purple
- food
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004369 blood Anatomy 0.000 title claims abstract description 73
- 239000008280 blood Substances 0.000 title claims abstract description 73
- 235000013305 food Nutrition 0.000 title claims abstract description 39
- 230000000087 stabilizing effect Effects 0.000 title claims abstract description 27
- 206010012601 diabetes mellitus Diseases 0.000 title claims abstract description 19
- 239000000843 powder Substances 0.000 claims abstract description 92
- 230000000694 effects Effects 0.000 claims abstract description 37
- 230000003647 oxidation Effects 0.000 claims abstract description 22
- 238000007254 oxidation reaction Methods 0.000 claims abstract description 22
- 235000009854 Cucurbita moschata Nutrition 0.000 claims abstract description 18
- 235000000832 Ayote Nutrition 0.000 claims abstract description 16
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 claims abstract description 16
- 235000021395 porridge Nutrition 0.000 claims abstract description 16
- 235000015136 pumpkin Nutrition 0.000 claims abstract description 16
- 240000004244 Cucurbita moschata Species 0.000 claims abstract description 15
- 235000019764 Soybean Meal Nutrition 0.000 claims abstract description 15
- 230000003064 anti-oxidating effect Effects 0.000 claims abstract description 15
- 239000004455 soybean meal Substances 0.000 claims abstract description 15
- 244000062793 Sorghum vulgare Species 0.000 claims abstract description 14
- 235000013336 milk Nutrition 0.000 claims abstract description 14
- 210000004080 milk Anatomy 0.000 claims abstract description 14
- 239000008267 milk Substances 0.000 claims abstract description 14
- 235000019713 millet Nutrition 0.000 claims abstract description 14
- 235000017060 Arachis glabrata Nutrition 0.000 claims abstract description 13
- 244000105624 Arachis hypogaea Species 0.000 claims abstract description 13
- 235000010777 Arachis hypogaea Nutrition 0.000 claims abstract description 13
- 235000018262 Arachis monticola Nutrition 0.000 claims abstract description 13
- 241000238557 Decapoda Species 0.000 claims abstract description 13
- 240000007049 Juglans regia Species 0.000 claims abstract description 13
- 235000009496 Juglans regia Nutrition 0.000 claims abstract description 13
- 235000012054 meals Nutrition 0.000 claims abstract description 13
- 235000020232 peanut Nutrition 0.000 claims abstract description 13
- 235000020234 walnut Nutrition 0.000 claims abstract description 13
- 235000013311 vegetables Nutrition 0.000 claims abstract description 12
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 claims abstract description 11
- 102000002322 Egg Proteins Human genes 0.000 claims abstract description 11
- 108010000912 Egg Proteins Proteins 0.000 claims abstract description 11
- 235000014103 egg white Nutrition 0.000 claims abstract description 11
- 210000000969 egg white Anatomy 0.000 claims abstract description 11
- 239000002994 raw material Substances 0.000 claims abstract description 11
- 235000014347 soups Nutrition 0.000 claims abstract description 11
- 240000007124 Brassica oleracea Species 0.000 claims abstract description 10
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 claims abstract description 10
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 claims abstract description 10
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 claims abstract description 10
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims abstract description 9
- 241000946641 Allium canadense var. mobilense Species 0.000 claims abstract description 9
- 235000015099 wheat brans Nutrition 0.000 claims abstract description 9
- 241001107116 Castanospermum australe Species 0.000 claims abstract description 6
- 235000021279 black bean Nutrition 0.000 claims abstract description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims description 22
- 238000001727 in vivo Methods 0.000 claims description 18
- 230000001737 promoting effect Effects 0.000 claims description 18
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 17
- 239000008103 glucose Substances 0.000 claims description 17
- 235000016709 nutrition Nutrition 0.000 claims description 16
- 239000003963 antioxidant agent Substances 0.000 claims description 15
- 238000010521 absorption reaction Methods 0.000 claims description 10
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 claims description 9
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims description 8
- 235000021307 Triticum Nutrition 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 8
- 230000015572 biosynthetic process Effects 0.000 claims description 7
- 229910052804 chromium Inorganic materials 0.000 claims description 7
- 239000011651 chromium Substances 0.000 claims description 7
- 230000001965 increasing effect Effects 0.000 claims description 7
- 230000028327 secretion Effects 0.000 claims description 6
- 230000035945 sensitivity Effects 0.000 claims description 6
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims description 6
- 230000011132 hemopoiesis Effects 0.000 claims description 5
- 238000003786 synthesis reaction Methods 0.000 claims description 5
- 102000001554 Hemoglobins Human genes 0.000 claims description 4
- 108010054147 Hemoglobins Proteins 0.000 claims description 4
- 108060003951 Immunoglobulin Proteins 0.000 claims description 4
- 102000018358 immunoglobulin Human genes 0.000 claims description 4
- 230000003914 insulin secretion Effects 0.000 claims description 4
- 235000006286 nutrient intake Nutrition 0.000 claims description 4
- 206010022489 Insulin Resistance Diseases 0.000 claims description 3
- 238000009472 formulation Methods 0.000 claims description 3
- 230000003111 delayed effect Effects 0.000 claims description 2
- 241000209140 Triticum Species 0.000 claims 2
- 210000003701 histiocyte Anatomy 0.000 claims 1
- 230000006641 stabilisation Effects 0.000 claims 1
- 238000011105 stabilization Methods 0.000 claims 1
- 208000024891 symptom Diseases 0.000 claims 1
- 239000003814 drug Substances 0.000 abstract description 15
- 244000068988 Glycine max Species 0.000 abstract description 10
- 235000010469 Glycine max Nutrition 0.000 abstract description 10
- 210000004153 islets of langerhan Anatomy 0.000 abstract description 2
- 241001247821 Ziziphus Species 0.000 abstract 1
- 235000012970 cakes Nutrition 0.000 abstract 1
- 230000007547 defect Effects 0.000 abstract 1
- 230000006806 disease prevention Effects 0.000 abstract 1
- 208000030159 metabolic disease Diseases 0.000 abstract 1
- 230000006870 function Effects 0.000 description 26
- 230000004060 metabolic process Effects 0.000 description 19
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 18
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 15
- 235000013312 flour Nutrition 0.000 description 15
- 206010028980 Neoplasm Diseases 0.000 description 14
- 235000006708 antioxidants Nutrition 0.000 description 14
- 201000011510 cancer Diseases 0.000 description 12
- 210000003734 kidney Anatomy 0.000 description 12
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 11
- 239000011575 calcium Substances 0.000 description 11
- 229910052791 calcium Inorganic materials 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 11
- 230000035764 nutrition Effects 0.000 description 11
- 201000010099 disease Diseases 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 235000019197 fats Nutrition 0.000 description 10
- 239000011718 vitamin C Substances 0.000 description 10
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 9
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 9
- 229930003268 Vitamin C Natural products 0.000 description 9
- 239000011574 phosphorus Substances 0.000 description 9
- 229910052698 phosphorus Inorganic materials 0.000 description 9
- 102000004169 proteins and genes Human genes 0.000 description 9
- 108090000623 proteins and genes Proteins 0.000 description 9
- 235000019154 vitamin C Nutrition 0.000 description 9
- 244000098338 Triticum aestivum Species 0.000 description 8
- 235000012000 cholesterol Nutrition 0.000 description 8
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 8
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 229940088594 vitamin Drugs 0.000 description 8
- 229930003231 vitamin Natural products 0.000 description 8
- 235000013343 vitamin Nutrition 0.000 description 8
- 239000011782 vitamin Substances 0.000 description 8
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 7
- 230000006378 damage Effects 0.000 description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 6
- 229930003316 Vitamin D Natural products 0.000 description 6
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 6
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 229910052742 iron Inorganic materials 0.000 description 6
- 229960003284 iron Drugs 0.000 description 6
- 230000001105 regulatory effect Effects 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- 235000019166 vitamin D Nutrition 0.000 description 6
- 239000011710 vitamin D Substances 0.000 description 6
- 150000003710 vitamin D derivatives Chemical class 0.000 description 6
- 229940046008 vitamin d Drugs 0.000 description 6
- 239000011701 zinc Substances 0.000 description 6
- 229910052725 zinc Inorganic materials 0.000 description 6
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 5
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 5
- 244000126002 Ziziphus vulgaris Species 0.000 description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 5
- 230000032683 aging Effects 0.000 description 5
- 229940024606 amino acid Drugs 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 5
- 150000001746 carotenes Chemical class 0.000 description 5
- 235000005473 carotenes Nutrition 0.000 description 5
- 239000010949 copper Substances 0.000 description 5
- 229910052802 copper Inorganic materials 0.000 description 5
- 229940108928 copper Drugs 0.000 description 5
- 235000005911 diet Nutrition 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 230000036039 immunity Effects 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 235000015097 nutrients Nutrition 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 231100000331 toxic Toxicity 0.000 description 5
- 230000002588 toxic effect Effects 0.000 description 5
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 5
- 241000234282 Allium Species 0.000 description 4
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 4
- 235000010149 Brassica rapa subsp chinensis Nutrition 0.000 description 4
- 235000000536 Brassica rapa subsp pekinensis Nutrition 0.000 description 4
- 241000499436 Brassica rapa subsp. pekinensis Species 0.000 description 4
- 102000004877 Insulin Human genes 0.000 description 4
- 108090001061 Insulin Proteins 0.000 description 4
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 4
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 4
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 4
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- 150000001720 carbohydrates Chemical class 0.000 description 4
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- 230000035622 drinking Effects 0.000 description 4
- 230000002708 enhancing effect Effects 0.000 description 4
- 206010016256 fatigue Diseases 0.000 description 4
- 229960000304 folic acid Drugs 0.000 description 4
- 235000019152 folic acid Nutrition 0.000 description 4
- 239000011724 folic acid Substances 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 229940125396 insulin Drugs 0.000 description 4
- 210000000936 intestine Anatomy 0.000 description 4
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 description 4
- 235000019136 lipoic acid Nutrition 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 239000011664 nicotinic acid Substances 0.000 description 4
- 239000011591 potassium Substances 0.000 description 4
- 229910052700 potassium Inorganic materials 0.000 description 4
- 235000007686 potassium Nutrition 0.000 description 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 4
- 229910052711 selenium Inorganic materials 0.000 description 4
- 239000011669 selenium Substances 0.000 description 4
- 229960002663 thioctic acid Drugs 0.000 description 4
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 4
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 4
- 235000010374 vitamin B1 Nutrition 0.000 description 4
- 239000011691 vitamin B1 Substances 0.000 description 4
- 150000003722 vitamin derivatives Chemical class 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 208000024172 Cardiovascular disease Diseases 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 240000001980 Cucurbita pepo Species 0.000 description 3
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 102000016943 Muramidase Human genes 0.000 description 3
- 108010014251 Muramidase Proteins 0.000 description 3
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 3
- 240000007594 Oryza sativa Species 0.000 description 3
- 235000007164 Oryza sativa Nutrition 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 102000019197 Superoxide Dismutase Human genes 0.000 description 3
- 108010012715 Superoxide dismutase Proteins 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 229930003451 Vitamin B1 Natural products 0.000 description 3
- 229930003779 Vitamin B12 Natural products 0.000 description 3
- 229930003427 Vitamin E Natural products 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 3
- 229960001231 choline Drugs 0.000 description 3
- 239000010941 cobalt Substances 0.000 description 3
- 229910017052 cobalt Inorganic materials 0.000 description 3
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 3
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 3
- 230000002354 daily effect Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 230000037149 energy metabolism Effects 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- -1 flavonoids compounds Chemical class 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 208000019622 heart disease Diseases 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 235000010335 lysozyme Nutrition 0.000 description 3
- 229960000274 lysozyme Drugs 0.000 description 3
- 239000004325 lysozyme Substances 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 235000001968 nicotinic acid Nutrition 0.000 description 3
- 229960003512 nicotinic acid Drugs 0.000 description 3
- 150000002831 nitrogen free-radicals Chemical class 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 239000001814 pectin Substances 0.000 description 3
- 206010036067 polydipsia Diseases 0.000 description 3
- 150000008442 polyphenolic compounds Chemical class 0.000 description 3
- 235000013824 polyphenols Nutrition 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 229960002477 riboflavin Drugs 0.000 description 3
- 235000009566 rice Nutrition 0.000 description 3
- 230000002000 scavenging effect Effects 0.000 description 3
- 230000009759 skin aging Effects 0.000 description 3
- 235000019605 sweet taste sensations Nutrition 0.000 description 3
- 229960003495 thiamine Drugs 0.000 description 3
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 3
- 230000010415 tropism Effects 0.000 description 3
- 239000011720 vitamin B Substances 0.000 description 3
- 235000019163 vitamin B12 Nutrition 0.000 description 3
- 239000011715 vitamin B12 Substances 0.000 description 3
- 239000011716 vitamin B2 Substances 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- 229940046009 vitamin E Drugs 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 230000037303 wrinkles Effects 0.000 description 3
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- 240000008654 Allium ramosum Species 0.000 description 2
- 235000005338 Allium tuberosum Nutrition 0.000 description 2
- 206010002198 Anaphylactic reaction Diseases 0.000 description 2
- 240000007087 Apium graveolens Species 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 2
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 208000002177 Cataract Diseases 0.000 description 2
- 208000019888 Circadian rhythm sleep disease Diseases 0.000 description 2
- 235000005602 Coleus parviflorus Nutrition 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 235000009852 Cucurbita pepo Nutrition 0.000 description 2
- 244000096857 Dioscorea batatas Species 0.000 description 2
- 235000002722 Dioscorea batatas Nutrition 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 208000001456 Jet Lag Syndrome Diseases 0.000 description 2
- 240000000599 Lentinula edodes Species 0.000 description 2
- 235000001715 Lentinula edodes Nutrition 0.000 description 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 208000000112 Myalgia Diseases 0.000 description 2
- 206010029240 Neuritis Diseases 0.000 description 2
- 244000061176 Nicotiana tabacum Species 0.000 description 2
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 2
- 235000000365 Oenanthe javanica Nutrition 0.000 description 2
- 206010060862 Prostate cancer Diseases 0.000 description 2
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 2
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 2
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 2
- RYMZZMVNJRMUDD-UHFFFAOYSA-N SJ000286063 Natural products C12C(OC(=O)C(C)(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 RYMZZMVNJRMUDD-UHFFFAOYSA-N 0.000 description 2
- 235000013559 Schnittsellerie Nutrition 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 229930003270 Vitamin B Natural products 0.000 description 2
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 2
- 229930003471 Vitamin B2 Natural products 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 229960001138 acetylsalicylic acid Drugs 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- ZOJBYZNEUISWFT-UHFFFAOYSA-N allyl isothiocyanate Chemical compound C=CCN=C=S ZOJBYZNEUISWFT-UHFFFAOYSA-N 0.000 description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 2
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 2
- 230000037354 amino acid metabolism Effects 0.000 description 2
- 230000036783 anaphylactic response Effects 0.000 description 2
- 208000003455 anaphylaxis Diseases 0.000 description 2
- 230000003266 anti-allergic effect Effects 0.000 description 2
- 230000002180 anti-stress Effects 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 235000013793 astaxanthin Nutrition 0.000 description 2
- 239000001168 astaxanthin Substances 0.000 description 2
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 2
- 229940022405 astaxanthin Drugs 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 208000002894 beriberi Diseases 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 230000000711 cancerogenic effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 210000001508 eye Anatomy 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 229960004580 glibenclamide Drugs 0.000 description 2
- ZNNLBTZKUZBEKO-UHFFFAOYSA-N glyburide Chemical compound COC1=CC=C(Cl)C=C1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCCCC2)C=C1 ZNNLBTZKUZBEKO-UHFFFAOYSA-N 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 208000026278 immune system disease Diseases 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 206010022000 influenza Diseases 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- 208000033915 jet lag type circadian rhythm sleep disease Diseases 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- 230000006651 lactation Effects 0.000 description 2
- 229960004488 linolenic acid Drugs 0.000 description 2
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 2
- 201000005202 lung cancer Diseases 0.000 description 2
- 208000020816 lung neoplasm Diseases 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 235000001055 magnesium Nutrition 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 208000010125 myocardial infarction Diseases 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 210000000496 pancreas Anatomy 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 230000019612 pigmentation Effects 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 2
- 235000005875 quercetin Nutrition 0.000 description 2
- 229960001285 quercetin Drugs 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 229960002855 simvastatin Drugs 0.000 description 2
- RYMZZMVNJRMUDD-HGQWONQESA-N simvastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)C(C)(C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 RYMZZMVNJRMUDD-HGQWONQESA-N 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 235000015424 sodium Nutrition 0.000 description 2
- 235000020354 squash Nutrition 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000002438 stress hormone Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 235000019156 vitamin B Nutrition 0.000 description 2
- 235000019164 vitamin B2 Nutrition 0.000 description 2
- 235000019158 vitamin B6 Nutrition 0.000 description 2
- 239000011726 vitamin B6 Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 229940011671 vitamin b6 Drugs 0.000 description 2
- BGKHCLZFGPIKKU-UHFFFAOYSA-N (13E,15S)-15-hydroxy-9-oxo-prosta-10,13-dienoic acid Natural products CCCCCC(O)C=CC1C=CC(=O)C1CCCCCCC(O)=O BGKHCLZFGPIKKU-UHFFFAOYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010000090 Abdominal rigidity Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 108010024957 Ascorbate Oxidase Proteins 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 206010008027 Cerebellar atrophy Diseases 0.000 description 1
- 208000018152 Cerebral disease Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 description 1
- 206010011732 Cyst Diseases 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N Daidzein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 1
- GMTUGPYJRUMVTC-UHFFFAOYSA-N Daidzin Natural products OC(COc1ccc2C(=O)C(=COc2c1)c3ccc(O)cc3)C(O)C(O)C(O)C=O GMTUGPYJRUMVTC-UHFFFAOYSA-N 0.000 description 1
- KYQZWONCHDNPDP-UHFFFAOYSA-N Daidzoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 201000004331 Henoch-Schoenlein purpura Diseases 0.000 description 1
- 206010019617 Henoch-Schonlein purpura Diseases 0.000 description 1
- 208000037319 Hepatitis infectious Diseases 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 208000031814 IgA Vasculitis Diseases 0.000 description 1
- 240000007171 Imperata cylindrica Species 0.000 description 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- 108010028554 LDL Cholesterol Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 206010024264 Lethargy Diseases 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 206010025323 Lymphomas Diseases 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 206010026749 Mania Diseases 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-N Nitrous acid Chemical compound ON=O IOVCWXUNBOPUCH-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 206010036105 Polyneuropathy Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000005107 Premature Birth Diseases 0.000 description 1
- 208000006399 Premature Obstetric Labor Diseases 0.000 description 1
- 206010036590 Premature baby Diseases 0.000 description 1
- 206010036600 Premature labour Diseases 0.000 description 1
- 208000015634 Rectal Neoplasms Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- AUYYCJSJGJYCDS-LBPRGKRZSA-N Thyrolar Chemical class IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-LBPRGKRZSA-N 0.000 description 1
- 208000008312 Tooth Loss Diseases 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 208000003441 Transfusion reaction Diseases 0.000 description 1
- 206010047623 Vitamin C deficiency Diseases 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 235000006545 Ziziphus mauritiana Nutrition 0.000 description 1
- 235000008529 Ziziphus vulgaris Nutrition 0.000 description 1
- 229910001297 Zn alloy Inorganic materials 0.000 description 1
- ZQBZAOZWBKABNC-UHFFFAOYSA-N [P].[Ca] Chemical compound [P].[Ca] ZQBZAOZWBKABNC-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 235000016720 allyl isothiocyanate Nutrition 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- 239000003200 antithyroid agent Substances 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000004531 blood pressure lowering effect Effects 0.000 description 1
- 230000004221 bone function Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 230000006931 brain damage Effects 0.000 description 1
- 231100000874 brain damage Toxicity 0.000 description 1
- 208000029028 brain injury Diseases 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 235000021152 breakfast Nutrition 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 230000036996 cardiovascular health Effects 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 230000011712 cell development Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 230000004098 cellular respiration Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 230000001906 cholesterol absorption Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- KYQZWONCHDNPDP-QNDFHXLGSA-N daidzein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-QNDFHXLGSA-N 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000018823 dietary intake Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 201000010582 ecthyma Diseases 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 229930182486 flavonoid glycoside Natural products 0.000 description 1
- 150000007955 flavonoid glycosides Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000002641 glycemic effect Effects 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000037219 healthy weight Effects 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000007475 hemolytic anemia Diseases 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 208000015446 immunoglobulin a vasculitis Diseases 0.000 description 1
- 230000000091 immunopotentiator Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 239000011229 interlayer Substances 0.000 description 1
- 201000002313 intestinal cancer Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000035987 intoxication Effects 0.000 description 1
- 231100000566 intoxication Toxicity 0.000 description 1
- KFZAUHNPPZCSCR-UHFFFAOYSA-N iron zinc Chemical compound [Fe].[Zn] KFZAUHNPPZCSCR-UHFFFAOYSA-N 0.000 description 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- 229940091250 magnesium supplement Drugs 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 229960003105 metformin Drugs 0.000 description 1
- XZWYZXLIPXDOLR-UHFFFAOYSA-N metformin Chemical compound CN(C)C(=N)NC(N)=N XZWYZXLIPXDOLR-UHFFFAOYSA-N 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 201000006417 multiple sclerosis Diseases 0.000 description 1
- 230000004220 muscle function Effects 0.000 description 1
- 201000000585 muscular atrophy Diseases 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 210000001087 myotubule Anatomy 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000030363 nerve development Effects 0.000 description 1
- 229960001597 nifedipine Drugs 0.000 description 1
- HYIMSNHJOBLJNT-UHFFFAOYSA-N nifedipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- XKLJHFLUAHKGGU-UHFFFAOYSA-N nitrous amide Chemical compound ON=N XKLJHFLUAHKGGU-UHFFFAOYSA-N 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 238000001668 nucleic acid synthesis Methods 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 210000000963 osteoblast Anatomy 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 230000003863 physical function Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 230000007824 polyneuropathy Effects 0.000 description 1
- 208000022530 polyphagia Diseases 0.000 description 1
- 229960003975 potassium Drugs 0.000 description 1
- 208000026440 premature labor Diseases 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 206010038038 rectal cancer Diseases 0.000 description 1
- 201000001275 rectum cancer Diseases 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 1
- 208000010233 scurvy Diseases 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 230000009758 senescence Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 235000001508 sulfur Nutrition 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 235000021147 sweet food Nutrition 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 239000005495 thyroid hormone Substances 0.000 description 1
- 229940036555 thyroid hormone Drugs 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 229960003232 troxerutin Drugs 0.000 description 1
- 230000002861 ventricular Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
- A23L11/05—Mashed or comminuted pulses or legumes; Products made therefrom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L17/00—Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
- A23L17/10—Fish meal or powder; Granules, agglomerates or flakes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/01—Instant products; Powders; Flakes; Granules
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L23/00—Soups; Sauces; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L25/00—Food consisting mainly of nutmeat or seeds; Preparation or treatment thereof
- A23L25/30—Mashed or comminuted products, e.g. pulp, pastes, meal, powders; Products made therefrom, e.g. blocks, flakes, snacks; Liquid or semi-liquid products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/115—Cereal fibre products, e.g. bran, husk
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/612—Crustaceans, e.g. crabs, lobsters, shrimps, krill or crayfish; Barnacles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/52—Juglandaceae (Walnut family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Nutrition Science (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Diabetes (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Emergency Medicine (AREA)
- Agronomy & Crop Science (AREA)
- Insects & Arthropods (AREA)
Abstract
本发明提供了一种用于二型糖尿病患者平稳血糖的食品配方，由以下原料组成粥、汤、饼子。粥、汤原料为：紫麦2号麦麸、黄豆粉、黑豆粉、紫枣粉、花生粉、核桃粉、鸡蛋清粉、海虾粉、紫洋葱粉、甘蓝粉、菜花粉、香菇粉、牛奶粉、南瓜粉、小米面、黄豆面。将以上原料分为三餐，日常餐用。具有保护胰岛活性，保持体内氧化与抗氧化平衡，克服体内代谢紊乱，从根本上保持血糖平稳等特点，克服了西医的治标、中医的难接受的弱点，具有适应强、易坚持、根稳糖、防病发等特点。
Description
技术领域
本发明所涉及的是调理饮食结构、平衡摄入营养的食品领域，特别涉及一种用于二型糖尿病患者平稳血糖的食品配方。
背景技术、
目前，对二型糖尿病的治疗，采取的措施有西医、中医，以西医治疗为主，使血糖数量得以表面控制，没能从根本上保护组织细胞对葡萄糖的吸收及胰岛β细胞对葡萄糖的敏感性；中医治本，但由于药效慢、成本高，不适宜体内日常代谢，出现病情反复发作，时间长了之后，导致糖尿病并发症(眼、肾、心脏、血管、神经、病足等)的发作。中、西医措施都难以落实到人体的日常代谢，不能从根本上长期稳定血糖，难以保护患者的身体健康。据不完全统计，中国二型糖尿病发病率飞速提高，占全国总人口的15％以上，并且患者认为：“糖尿病不是病，是死不了的癌症”，并对该病的治疗措施产生了猜疑、厚望！
发明内容
本发明一种用于二型糖尿病患者平稳血糖食品配方，以解决上述背景技术提出的问题。
为实现上述目的本发明提供如下技术方案有二：第一、根据铬对人体的功能，满足胰岛β细胞活性所需营养三价铬的摄入，保护组织细胞对葡萄糖的吸收及胰岛β细胞对葡萄糖的敏感性，维持正常血清胆固醇水平，促进脂肪消耗，促进血红蛋白合成及造血， 增加免疫球蛋白；第二、满足十大抗氧化剂营养摄入，维持体内氧化与抗氧化的相对平衡， 避免胰岛素抵抗增多、胰岛素分泌减少、分泌高峰延迟、血糖波动加剧等。十大抗氧化 剂主要功能见如下表一、表二：
十大抗氧化剂主要功能《表一》
十大抗氧化剂主要功能《表二》
本方案用于二型糖尿病患者平稳血糖的食品配方，由以下份数的原料组成：粥、汤：特育紫麦2号麦麸15-25份、黄豆粉3-7份、黑豆粉4-6份、紫枣粉30-50份、花生粉7-13份、核桃粉12-18份、鸡蛋清粉13-17份、海虾粉11-17份、紫洋葱粉6-10份、甘蓝粉2- 8份、菜花粉1-3份、香菇粉1-5份、牛奶粉30-54份、南瓜粉2-8份；面食：小米面80- 120份、黄豆面90-110份。本发明的优选配方是：粥汤：特育紫麦2号麦麸20份、黄豆粉 5份、黑豆粉5份、紫枣粉40份、花生粉10份、核桃粉15份、鸡蛋清粉15份、海虾粉14 份、紫洋葱粉8份、甘蓝粉5份、菜花粉2份、香菇粉3份、牛奶粉42份、南瓜粉5份；面食：小米面100份、黄豆面100份。
本配方的食用方法：将以上原料分为粥、汤、面如下：
粥、汤为：早、中、晚三餐饮用。三餐分配方案为：早粥：特育紫麦2号麦麸、黄豆粉、黑豆粉、紫枣粉、花生粉、核桃粉、鸡蛋清粉，将这些原料用豆浆机加750ml水，熬制成浆饮用；中汤：海虾粉、紫洋葱粉、甘蓝粉、菜花粉、香菇粉(如同炒菜，中间加水 300-500ml，温饮)、牛奶粉(加适量温水冲饮)；晚粥：南瓜粉(与最少量米、面一同熬粥饮用)。面为：小米、黄豆面粉蒸做成饼子，作为早、中晚面食。
本发明原料配方的核心作用有二：第一、保护组织细胞对葡萄糖的吸收及胰岛β细胞对葡萄糖的敏感性，维持正常血清胆固醇水平，促进脂肪消耗，促进血红蛋白合成及造血，增加免疫球蛋白；第二、维持体内氧化与抗氧化的相对平衡，避免胰岛素抵抗增多、胰岛素分泌减少、分泌高峰延迟、血糖波动加剧等。
各原料的主要功能如下：
特育紫麦2号麦麸：性味：味甘，性凉。无毒。归经：归大肠经。除热，止渴，敛汗，消肿。主治虚汗，盗汗，泄痢，糖尿病，口腔炎，热疮，折伤，风湿痹痛，脚气。在平稳血糖方面，用其来主要发挥两种作用：一是满足胰岛活性所需的三价铬：保护组织细胞对葡萄糖的吸收及胰岛β细胞对葡萄糖的敏感性，维持正常血清胆固醇水平，促进脂肪消耗，促进血红蛋白合成及造血，增加免疫球蛋白；二是在体内正常代谢，维持氧化与抗氧化平衡方面，主要满足维生素e如下功能：1、防止肌肉萎缩、脑软化症及溶血性贫血的发生。2、延缓细胞衰老。3、有助于保持血小板的″光滑″，使其不易形成血栓。4、维持红细胞功能，提供内脏和肌肉所需氧气的量，降低老年人血液中胰岛素浓度。5、协助消除黄褐斑、減少皱纹出现。6、改善血液循环。7、提高生殖力、治疗不孕症及消除早产。
黄豆粉：[性能]味甘，性平。能健脾利湿，益血补虚，解毒。大豆富含异黄酮，可断绝癌细胞营养供应，含人体必需的8种氨基酸，多种维生素及多种微量元素，可降低血中胆固醇，预防高血压、冠心病、动肪硬化等。黄豆内含亚油酸，能促进儿童神经发育。含丰富的蛋白质，其中含人体必需的多种氨基酸，尤以赖氨酸含量最高；含大量脂肪，其中主要为不饱和脂肪酸(亚油酸、油酸、亚麻酸等)；并含磷酯、钙、磷、铁、钾、钠、胡萝卜素，维生素B1、B2、B12，烟酸、叶酸、胆碱、大豆黄酮甙、皂甙等成分。
黑豆粉：性味归经：味甘，性微寒，性平、入脾、肾经。功用：补肾益阴，健脾利湿，除热解毒。主治李时珍在《本草纲目》中有记载：“常食黑豆，可百病不生。”用于肾虚阴亏；服药中毒或饮酒过多等。成分含丰富的蛋白质、不饱和脂肪酸、磷酯、钙、磷、铁、钾、钠、胡萝卜素、维生素B1、维生素B2、维生素B12、烟酸、叶酸、棉子糖、水苏糖、胆碱、大豆黄酮、皂苷等。
花生粉：花生果实含有蛋白质、脂肪、糖类、维生素A、维生素B6、维生素E、维生素K，以及矿物质钙、磷、铁等营养成分，含有8种人体所需的氨基酸及不饱和脂肪酸，含卵磷脂、胆碱、胡萝卜素、粗纤维等物质。含有丰富的维生素B2、PP、A、D、E，钙、铁、锌等。并含有硫胺 素、核黄素、尼克酸等多种维生素。有促进人的脑细胞发育，增强记忆的作用。在平稳血糖、体内正常代谢、氧化与抗氧化平衡方面功能有二：一是用其所含锌主要发挥如下功能：1、200多种酶的活动中心。2、清除自由基，延缓衰老。3、在人体生长发育中大显身手。4、对创伤愈合疗效显著。5、对味觉的调控作用重大。6、与免疫。7、与生殖密切相关。二是用其所含辅酶Q-10发挥功能：1、它是细胞代谢和细胞呼吸激活剂。通过清除氧自由基，能使细胞保持良好状态，改善心室功能，加速脂肪代谢，从而使肢体和大脑的能量供应充足，精力旺盛。2、能防治心血管疾病、抗衰老、抗肿瘤。 3、提升免疫功能。4、维持健康体重、养颜美容、抗皮肤皱纹和延缓皮肤衰老。5、能防治细胞损伤引起的疾病。
核桃粉：核桃营养价值丰富，有“万岁子”“长寿果”“养生之宝”的美誉。核桃中86％的脂肪是不饱和脂肪酸，核桃富含铜、镁、钾、维生素B6、叶酸和维生素B1，也含有纤维、磷、烟酸、铁、维生素B2和泛酸。味甘、性平，温，无毒，微苦，微涩，入肾、肺、大肠经。可补肾、固精强腰、温肺定喘、润肠通便。主治：肾虚喘嗽、腰痛；(核中木质隔层) 味苦、性温；补肾，涩精。1.破血祛瘀：用于血滞经闭、血瘀腹痛、蓄血发狂、跌打瘀能等病症。2.润燥滑肠：用于肠燥便秘的大便难解。本品苦泄散瘀，入肝经血分，有较强的活血调经、祛瘀生新之功，适于血分瘀滞较重者。此外，兼有润肠、止咳之功。在平稳血糖、体内正常代谢、氧化与抗氧化平衡方面，用其所含锌发挥主要功能同“花生粉”。
枣粉：富含蛋白质、脂肪、糖类、胡萝卜素、B族维生素、维生素C、维生素P以及磷、钙、铁等成分，其中维生素C的含量在果品中名列前茅，有“天然维生素丸”之美称。枣性温、味甘，具益气补血、健脾和胃、袪风功效，对治疗过敏性紫癜、贫血、高血压、急慢性肝炎和肝硬化患者的血清转氨酶增高，以及预防输血反应等均有理想效果；大枣含有三萜类化合物及环磷酸腺苷，有较强的抑癌、抗过敏作用；枣中含有抗疲劳作用的物质能增强人的耐力；枣还具有减轻毒性物质对肝脏损害的功效；枣中的黄酮类化合物，有镇静降血压的作用。枣富含的环磷酸腺苷，是人体能量代谢的必需物质，能增强肌力、消除疲劳、扩张血管、增加心肌收缩力、改善心肌营养，对防治心血管疾病有良好的作用。在平稳血糖、体内正常代谢、氧化与抗氧化平衡方面，用其所含维生素C发挥主要功能为：1、促进胶原蛋白生成，保持骨骼、皮肤和关节的牢固和強健。2、具有抗氧化作用，有延年益寿作用。3、控制胆固醇及甘油三脂。4、帮助肝脏形成解毒物质。5、帮助钙、铜及铁吸收。 6、促进氨基酸代谢。7、抑制黒色素的形成。8、消除疲劳及肌肉痛。9、预防流行性感冒等病毒的入侵。10、有助于抗压力激素的分泌和食物能量的转化。11、有效治疗过敏症等免疫性疾病。12、预防白内障或防止白内障恶化。13、防止动脉粥样硬化，防治心脏病，促进胆固醇沉着。14、防治癌症，阻断肿瘤细胞的增殖。
鸡蛋清粉：鸡蛋清不但可以使皮肤变白，而且能使皮肤细嫩、去除死皮。这是因为它含有丰富的蛋白质和少量醋酸和溶菌酶，蛋白质可以增强皮肤的润滑作用，醋酸可以保护皮肤的微酸性，溶菌酶能杀灭细菌，两者共同避免皮肤遭受细菌感染。此外，鸡蛋清还具有清热解毒和增强皮肤免疫功能的作用。性味、甘，凉，无毒。功用主治、润肺利咽，清热解毒。治咽痛，目赤，咳逆，下肉，疟疾，烧伤，热毒肿痛。
海虾粉：营养价值1.虾营养丰富，且其肉质松软，易消化，对身体虚弱以及病后需要调养的人是极好的食物；2.虾中含有丰富的镁，镁对心脏活动具有重要的调节作用，能很好的保护心血管系统，它可减少血液中胆固醇含量，防止动脉硬化，同时还能扩张冠状动 脉，有利于预防高血压及心肌梗等；3.虾的通乳作用较强，并且富含磷、钙、对小儿、孕妇尤有补益功效；4.日本大阪大学的科学家发现，虾体内的虾青素有助于消除因时差反应而产生的“时差症”。性味、味甘，性微温。归经、归肝、胃、肾经。功效、补肾壮阳，通乳，托毒。主治用于肾虚阳痿，产妇乳少，麻疹透发不畅，阴疽，恶核，丹毒，臁疮。在平稳血糖、体内正常代谢、氧化与抗氧化、平衡方面，用其发挥主要功能有二：一是所含虾青素：1、眼和中枢神经系统的保护作用。2、防紫外线辐射。3、预防心血管疾病。4、增强免疫力。5、缓解运动疲劳，增强机体能量代谢。6、抗炎抗感染特性。7、抑制肿瘤。8、抑制糖尿病、肾病等等。二是所含硒：1、减少前列腺癌、直肠癌、肺癌的发生。2、预防心脏病。3、硒与维生素E混合使用，对于强化免疫。还能明显改善老人情绪。4、协助甲状腺激素产生作用，以降低人体脂肪堆积。5、防止生物血管脆弱破裂。
紫洋葱粉：洋葱中的营养成分十分丰富，不仅富含钾、维生素C、叶酸、锌、硒，及纤维质等营养素，更有两种特殊的营养物质-槲皮素和前列腺素A。这两种特殊营养物质，令洋葱具有了很多其他食物不可替代的健康功效：1、预防癌症、洋葱的防癌功效来自于它富含的硒元素和槲皮素。2、维护心血管健康。3、刺激食欲，帮助消化。4、杀菌、抗感冒。 5、洋葱对“富贵病”有很好的预防。在平稳血糖、体内正常代谢、氧化与抗氧化平衡方面，用其发挥主要功能有二：一是所含多酚：1、抗发炎。2、清除自由基。3抗病毒。4、抗过敏。5、抑制肿瘤。6、抗动脉硬化等。二是所含硫辛酸：1、保护及修复组织，改善因疾病引起的多发性神经病变。2、延缓肌肤衰老。3、既能抗氧自由基，又能抗氮自由基。氮自由基专门伤害脑，硫辛酸可以中和氮自由基。4、提高智商，改善记忆力。5、帮助控制糖和胰岛素水平，阻止过度糖化的终末产物(即AGEs)对人体的伤害。
甘蓝粉：营养价值：含葡萄糖芸苔素、黄酮甙、花白甙、绿原酸、异硫氰酸烯丙酯、含硫的抗甲状腺物质(可因加热而消失)、多量维生素U样物质，维生素B、C，胡萝卜素、钙、磷、铁等成分。甘蓝菜性味甘平，具有益脾和胃，缓急止痛作用，可以治疗上腹账气疼痛，嗜睡，脘腹拘急疼痛等疾病。在平稳血糖、体内正常代谢、氧化与抗氧化平衡方面，用其所含超氧化物歧化酶发挥主要功能为：1、修复细胞，降低细胞受损率。2、清徐超氧阴离子自由基。3、抗皱、防止色素沉着和皮肤衰老；作为食品添加剂可抗衰老。4、促进锌、铜、锰吸收。5、抗辐射损伤。6、治疗炎症及自身免疫性疾病等。
菜花粉：在平稳血糖、体内正常代谢、氧化与抗氧化平衡方面，用其所含维生素C发挥主要功能为：1、促进胶原蛋白生成，保持骨骼、皮肤和关节的牢固和強健；2、具有抗氧化作用，有延年益寿作用；3、控制胆固醇及甘油三脂；4、帮助肝脏形成解毒物质 5、帮助钙、铜及铁吸收 6、促进氨基酸代谢；7、抑制黒色素的形成；8、消除疲劳及肌肉痛；9、预防流行性感冒等病毒的入侵；10、有助于抗压力激素的分泌和食物能量的转化；11、有效治疗过敏症等免疫性疾病；12、预防白内障或防止白内障恶化； 13、防止动脉粥样硬化，防治心脏病，促进胆固醇沉着 14、防治癌症，阻断肿瘤细胞的增殖。
香菇粉：香菇是具有高蛋白、低脂肪、多糖、多种氨基酸和多种维生素的菌类食物。1. 提高机体免疫功能。2.延缓衰老。3.防癌抗癌。4.降血压、降血脂、降胆固醇。5.香菇还对糖尿病、肺结核、传染性肝炎、神经炎等起治疗作用，又可用于消化不良、便秘等。在平稳血糖、体内正常代谢、氧化与抗氧化平衡方面，用其所含维生素D发挥主要功能为：1、促进人体钙磷代谢，增强骨质、肌肉、体能和心脏等功能。2、改善免疫系统。3、能降低免疫老化，对抗衰老。4、防治淋巴瘤、前列腺癌、肺癌、甚至皮膚癌，而防治結肠癌最为突出。5、增大人体快肌纤维，增强肌肉力量，降低老年人跌倒和骨折的可能性。6、保护人的口腔卫生，降低牙齿脱落的可能性。7、降低多发性硬化症的患病率。
牛奶粉：营养价值：1、蛋白质：供给机体营养。2、脂肪：供给机体营养及能量，提供牛奶浓香。3、糖类：牛奶中含有乳糖，乳糖对于幼儿发育非常重要，它能促进人体肠道内有益菌的成长，仰制肠内异常发酵，有利肠道健康。4、矿物质：矿物质又称无机盐，是人体构成不可缺少的物质，包含钙、铁、磷、锌、铜、锰、钼等，特别是含钙丰富，且钙磷比例合理，吸收率高。5、维生素：牛奶中含有已知的所有维生素，其作用：维生素A促进正常生长与繁殖维持上皮组织与视力；维生素B参与体内糖及能量代谢；维生素C抗坏血病；维生素D能调节各代谢骨骼组织中的造骨细胞的钙化能力；维生素E抗氧化衰老。6、亚油酸、亚麻酸。
南瓜粉：多糖类、南瓜多糖是一种非特异性免疫增强剂，能提高机体免疫功能，促进细胞因子生成，通过活化补体等途径对免疫系统发挥多方面的调节功能。在平稳血糖、体内正常代谢、氧化与抗氧化平衡方面，用其所含β-胡萝卜素发挥主要功能为：(1)促进皮肤和黏膜细胞以及视网膜的正常工作，具有抗氧化、延缓衰老的作用。(2)具有防癌、抗癌免疫力。(3)减少自由基对心脏、血管的损伤，降低严重心脑病变如心肌梗死、中风等的发生。(4)具有阻止低密度脂蛋白胆固醇氧化的功能等。果胶：南瓜中的果胶能调节胃内食物的吸收速率，使糖类吸收减慢，可溶性纤维素能推迟胃内食物的排空，控制饭后血糖上升。果胶还能和体内多余的胆固醇结合在一起，使胆固醇吸收减少，血胆固醇浓度下降。矿质元素：南瓜含有丰富的钴，在各类蔬菜中含钴量居首位。钴能活跃人体的新陈代谢，促进造血功能，并参与人体内维生素B12的合成，是人体胰岛细胞所必须的微量元素。南瓜中所含的维生素C能防止硝酸盐在消化道中转变成致癌物质亚硝酸。南瓜中含有的甘露醇，减少粪便中毒素对人体的危害。南瓜能消除致癌物质亚硝胺的突变作用。有防癌功效。南瓜中含有丰富锌，参与人体内核酸、蛋白质合成，是肾上腺皮质激素的固有成分，为人体生长发育的重要物质。氨基酸：南瓜中含有人体所需的多种氨基酸，其中赖氨酸、亮氨酸、异亮氨酸、苯丙氨酸、苏氨酸等含量较高。此外，南瓜中的抗坏血酸氧化酶基因型与烟草中相同，但活性明显高于烟草，表明了在南瓜中免疫活性蛋白的含量较高。
小米粉：小米味甘、咸、性凉；入肾、脾、胃经；(陈粟米味苦，性寒)。其营养特性为：1.小米因富含维生素B1、B12等，具有防止消化不良及抗神经炎和预防脚气病的功效；2.小米具有防止反胃、呕吐的功效；3.还具有滋阴养血的功能，可以使产妇虚寒的体质得到调养，帮助她们恢复体力；4.小米具有减轻皱纹、色斑、色素沉着的功效。
与现有技术相比本发明的有益效果是：从病根入手，采取调理饮食结构，确保体内营养平衡摄入，保护体内正常代谢，效果如下：
(1)根稳。从根本上保护胰岛功能，保护体内组织细胞对葡萄糖的吸收及胰岛β细胞对葡萄糖的敏感性，克服病源，保持血糖稳定，恢复、保持二型糖尿病患者的身体健康。
(2)保健。维持体内正常代谢、氧化与抗氧化的平衡，克服氧化应激对胰岛β细胞的损伤及其所造成的胰岛素分泌水平降低、分泌高峰延迟、血糖波动加剧的现象。
(3)适应性强。从正常饮食的角度进行实施，患者易于接受并能长期维持，能够从根本上稳定血糖。克服西医的治标不治本和中医治本成本高、难接受、难坚持，难以长期保持血糖平稳的现实。
下面将结合本发明试验数据统计实例的技术方案进行清楚、完整地描述，显然，所描述的实例只是本发明的举例，而不是全部实施例。基于本发明所涉领域范围，都属于本发明保护范围。
具体实施方式
下面结合具体实施方式对本专利的技术方案作进一步详细说明：实施例1
山东省平原县恩城镇村，衷某，女，母亲患有糖尿病，务农，劳动量严重超标。
一、随意饮食的表现：日常随意饮食为：每日食用普通小麦标准面粉400克蒸做 的馒头；早餐玉米粉(20克左右)粥；晚餐40克左右大米稀饭；蔬菜：白菜、芹菜、韭 菜、土豆为主，每日食用其中一种，数量为300克左右，菜中有时加上一个鸡蛋(50克左 右)， 摄入铬、十大抗氧化剂数量、类别见表如下：
注：1、表中没计算十大抗氧化剂中维生素D，原因是日照即可满足人体需要。2、营养元素含量分别来源于：(1)参考 ″电脑百度文库《食品中铬元素的含量分析》张凤珍、张元英、史仁玖、孙凌云，泰山医学院生物化学教研室，山东泰 安″，(2)枣、花生、核桃、鸡蛋清、牛奶含量来源于：《食物营养搭配速查全书》中国轻工业出版社、科学技术文献出 版社，编辑韩磊、双福；其它来源于：电脑百度文库″食品营养成分表″。
2012年6月6日，54岁，出现多食、多饮、烦渴，自测空腹血糖10.8mmol/l，超标了(空 腹血糖正常范围为3.8-6.28mmol/l。
二、食用本发明食品配方平稳血糖期效果：服用药物同时进行调膳：食用了：“一种用于二型糖尿病患者平稳血糖的食品配方”，由以下份数的原料组成：粥、汤：特育紫麦2号麦麸15-25份、黄豆粉3-7份、黑豆粉4-6份、紫枣粉30-50份、花生粉7-13份、核桃粉 12-18份、鸡蛋清粉13-17份、海虾粉11-17份、紫洋葱粉6-10份、甘蓝粉2-8份、菜花粉1-3份、香菇粉1-5份、牛奶粉30-54份、南瓜粉2-8份；面食：小米面80-120份、黄豆面90-110份。食用期限达3个月，自测空腹血糖5.68mmol/l。
三、坚持食用本发明食品配方平稳血糖的功效：一直保持本专利食品配方的食用，不再服用药物，空腹血糖保持在3.8mmol/l.-6.2mmol/l.正常范围内。
四、专利实施血糖指数对比
(一)、实施活胰营养、十大抗氧化剂应摄、实摄数量，血糖对比表如下：
注：1、表中没计算十大抗氧化剂中维生素D，原因是日照即可满足人体需要；2、表中多酚、 辅酶Q-10、超氧化物歧化酶、硫辛酸只计算摄入类别不计算摄入数量。
(二)、不同时期平稳血糖措施效果对比表：
析如下：血糖平稳原因：在于本发明食品配方，一是、从根本上满足胰岛活性所需营养摄入量；二是、为体内正常代谢、氧化与抗氧化平衡铺平了道路，保持人体内营养的平衡、足量摄入。
实施例2
山东省平原县恩城镇元官屯村郑某，女，无劳动能力，夫妻二人相互照顾，较难自理。2006年3月10日，70岁，始患糖尿病、小脑萎缩。
一、采用目前医疗措施，平稳血糖效果表现：2006年3月10日-2012年11月10 日，平稳血糖医疗措施、效果表现如下：
(一)医疗措施和随意饮食：1、服用药物6种(硝苯地平、曲克芦丁、阿司匹林、 辛伐他丁、二甲双胍、格列本脲)，同时还注射胰岛素4个单位，每日2次；2、饮食上随 自己意愿：每日300克普通小麦面粉制作的馒头，早粥玉米20克、晚饭大米40克；蔬菜： 随意数量不足80克/日，忌甜食，摄入铬、十大抗氧化剂数量、类别见表如下：
注：同[0038]表下的“注”
(二)医疗效果表现：2006年3月10日-2011年3月18日，7年时间，血糖降不到正常范围3.8-6.28mmol/l内，《山东省平原第一人民医院》检验报告单上：血糖控制指数12.0mmol/L。
二、食用本发明食品配方平稳血糖的效果
(一)、实施本发明的平稳血糖食品配方，依据如下：
食用了本发明“一种用于二型糖尿病患者平稳血糖的食品配方”，优选配方是： 粥汤：紫麦2号麦麸20份、黄豆粉5份、黑豆粉5份、紫枣粉40份、花生粉10份、核 桃粉15份、鸡蛋清粉15份、海虾粉14份、紫洋葱粉8份、甘蓝粉5份、菜花粉2份、 香菇粉3份、牛奶粉42份、南瓜粉5份；面食：小米面100份、黄豆面100份，摄入铬、 十大抗氧化剂数量、类别见表如下；
注：同[0039]表下。
(二)、实施时间：2012年11月13日-2013年2月3日，共80日。
(三)、实施效果：2013年2月3日，《山东省平原第一人民医院》检查空腹血糖值降到6.4mmol/L.
三、坚持食用本发明食品配方平稳血糖的功效：2013年2月3日，空腹血糖降到6.4mmol/L之后，坚持食品配方的食用，2013年3月之后，去消了胰岛素的注射和阿司匹林、辛伐他丁药物的服用，2014年3月之后，间歇性服用格列本脲。直至2018年6月，四年多的时间，空腹血糖一直保持在5.7mmol/L左右。
四、专利实施血糖指数对比
(一)实施活胰营养、十大抗氧化剂应摄、实摄数量，血糖对比表如下：
注：1、表中不计维生素D，原因是日照人体即可满足；2、表中多酚、辅酶Q-10、超氧化物 歧化酶、硫辛酸只计算摄入类别不计算摄入数量。
(二)不同时期平稳血糖措施效果对比表：
分析如下：血糖平稳原因：在于本发明食品配方，一是、从根本上满足胰岛活性所需营养摄入量；二是、为体内正常代谢、氧化与抗氧化平衡铺平了道路，保持人体内营养的平衡、足量摄入。
以上所述仅为本发明的实施实例而已，并不用以限制本发明，凡在本发明的精神和原则之内所做的任何修改、等同替换、改进等，均应包含在本发明的保护范围之内。
Claims (3)
1.一种用于二型糖尿病患者平稳血糖的食品配方，其特征在于：第一、满足胰岛β细胞活性所需营养三价铬的摄入，保护组织细胞对葡萄糖的吸收及胰岛β细胞对葡萄糖的敏感性，维持正常血清胆固醇水平，促进脂肪消耗，促进血红蛋白合成及造血，增加免疫球蛋白；第二、满足十大抗氧化剂营养摄入，维持体内氧化与抗氧化的相对平衡，避免胰岛素抵抗增多、胰岛素分泌减少、分泌高峰延迟、血糖波动加剧等症状发生。
2.根据权利要求1所述的一种用于二型糖尿病患者平稳血糖的食品配方，其特征在于，由以下份数的原料组成：粥、汤：特育紫麦2号麦麸15-25份、黄豆粉3-7份、黑豆粉4-6份、紫枣粉30-50份、花生粉7-13份、核桃粉12-18份、鸡蛋清粉13-17份、海虾粉11-17份、紫洋葱粉6-10份、甘蓝粉2-8份、菜花粉1-3份、香菇粉1-5份、牛奶粉30-54份、南瓜粉2-8份；面食：小米80-120份、黄豆粉90-110份。
3.根据权利要求1所述的一种用于二型糖尿病患者平稳血糖的食品配方，其特征在于，本发明的优选配方是：粥汤：特育紫麦2号麦麸20份、黄豆粉5份、黑豆粉5份、紫枣粉40份、花生粉10份、核桃粉15份、鸡蛋清粉15份、海虾粉14份、紫洋葱粉8份、甘蓝粉5份、菜花粉2份、香菇粉3份、牛奶粉42份、南瓜粉5份；面食：小米100份、黄豆粉100份。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810914758.4A CN110800914A (zh) | 2018-08-04 | 2018-08-04 | 一种用于二型糖尿病患者平稳血糖的食品配方 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810914758.4A CN110800914A (zh) | 2018-08-04 | 2018-08-04 | 一种用于二型糖尿病患者平稳血糖的食品配方 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110800914A true CN110800914A (zh) | 2020-02-18 |
Family
ID=69487221
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810914758.4A Pending CN110800914A (zh) | 2018-08-04 | 2018-08-04 | 一种用于二型糖尿病患者平稳血糖的食品配方 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110800914A (zh) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102113652A (zh) * | 2009-12-30 | 2011-07-06 | 徐秀卿 | 一种适合“五高”代谢综合症人群的特膳挤压米及其制备方法 |
| CN105661522A (zh) * | 2016-01-15 | 2016-06-15 | 衷成华 | 一种对二型糖尿病人平稳血糖进行推荐的方法 |
| CN105901516A (zh) * | 2016-04-22 | 2016-08-31 | 河南科技大学 | 一种富含彩色麦麸膳食纤维的营养方便粥及其制备方法 |
| CN107536057A (zh) * | 2017-10-23 | 2018-01-05 | 深圳联盛诺康控股有限公司 | 一种用于调理糖尿病患者的食品配方 |
-
2018
- 2018-08-04 CN CN201810914758.4A patent/CN110800914A/zh active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102113652A (zh) * | 2009-12-30 | 2011-07-06 | 徐秀卿 | 一种适合“五高”代谢综合症人群的特膳挤压米及其制备方法 |
| CN105661522A (zh) * | 2016-01-15 | 2016-06-15 | 衷成华 | 一种对二型糖尿病人平稳血糖进行推荐的方法 |
| CN105901516A (zh) * | 2016-04-22 | 2016-08-31 | 河南科技大学 | 一种富含彩色麦麸膳食纤维的营养方便粥及其制备方法 |
| CN107536057A (zh) * | 2017-10-23 | 2018-01-05 | 深圳联盛诺康控股有限公司 | 一种用于调理糖尿病患者的食品配方 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107173694A (zh) | 一种营养全面平衡的全素食代餐粉配方 | |
| CN103229963B (zh) | 一种经发芽处理的杂粮食品及其制备方法 | |
| KR101090284B1 (ko) | 홍삼과 녹용 추출물을 포함하는 드링크제 및 그의 제조방법 | |
| CN107156623A (zh) | 一种复合谷物混合物及其制备方法 | |
| CN102524659A (zh) | 一种具有营养保健功能的粮食配方 | |
| CN105285952A (zh) | 一种营养均衡的代餐粉及其制备方法 | |
| CN102813120B (zh) | 海参防癌降糖面粉及制备方法 | |
| CN101658261B (zh) | 山珍系列挂面 | |
| CN104171985A (zh) | 一种均衡营养复合型芽苗健康食品 | |
| CN103005450A (zh) | 一种营养速食方便食品及其制备方法 | |
| CN106858215A (zh) | 一种百香果复合饮料 | |
| CN104799317A (zh) | 一种甘薯饼干及其制备方法 | |
| CN113712199A (zh) | 食叶草减肥代餐食品 | |
| CN103168815A (zh) | 一种银杏苦荞饼干及其制作方法 | |
| CN111184214A (zh) | 酵素胶原蛋白杂粮果蔬即食代餐粥及其制作方法 | |
| CN103704568B (zh) | 临床膳食食品 | |
| CN105380073A (zh) | 一种糖尿病营养餐冲剂 | |
| KR20030013221A (ko) | 양파분, 양파장아찌, 양파간장, 양파고추장, 양파된장제조방법 | |
| CN104431716A (zh) | 莲子整枣营养粥及制作方法 | |
| KR20150083638A (ko) | 성장촉진 조성물 | |
| KR20050115836A (ko) | 현미배아,소맥배아, 발아현미등 각종영양재료를 주제로한균형식품 | |
| CN113749152A (zh) | 一种健康养生强身饮品及其制备方法 | |
| CN103461817B (zh) | 一种含木鱼石粉的营养馒头 | |
| CN110800914A (zh) | 一种用于二型糖尿病患者平稳血糖的食品配方 | |
| CN110839825A (zh) | 一种杂粮空心面的制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |